Universitas Airlangga

This quasi-experimental study focuses on Indonesian nursing students and aims to examine the effectiveness of virtual reality (VR) dementia educational programs. The study addresses the following research questions:
1. What is the current state of knowledge and awareness about dementia among participants before engaging in a VR dementia education program?
2. What is the effect of a VR dementia education program on improving participants' attitude, knowledge, and intention to help toward people living with dementia, and how are participants satisfied with the VR dementia education program? Participants will voluntarily join a 120-minute class education program, with each participant attending only once. The program, integrated into the faculty's dementia-related courses, will be structured around a series of components, including introduction, pre-program questionnaire, lecture, bad drama (unfriendly communication), bad version of VR, discussion, Lecture (about dementia), good VR, good drama, Lecture, N-impro, post-program questionnaire, and conclusion.
The VR education program will be included in dementia-related courses in the faculty of nursing.

This clinical trial aims to learn if there is a relationship between OWT/OB and IDA in nonpregnant women of reproductive age and its impact on iron supplementation. The main questions it aims to answer are:
* Is there any independent association between overweight/obesity and iron deficiency anemia in nonpregnant women after controlling for potential confounding factors?
* Does the effect of iron supplementation on iron status vary between overweight/obese and normal-weight nonpregnant women (as measured by multiple iron biomarkers)? Researchers will compare several biomarkers between the case and control groups after the intervention is given for 90 days.
Participants will:
* Visit the research center before the intervention given and after 90 days
* Take daily iron-folic acid supplements for 90 days
* Keep a diary of their supplement's intake

The goal of this open-label clinical trial is to evaluate the safety and immunogenicity of INAVAC (Vaksin Merah Putih - UNAIR SARS-CoV-2 (Vero Cell Inactivated)) Vaccine as Homologue Booster in Adult Subjects in Indonesia. The main question it aims to answer is: "To evaluate the humoral immunogenicity profile at 28 days following vaccination with INAVAC vaccine as homolog booster administered intramuscularly in healthy adults age 18 years and above". Participants will be administered one dose of vaccination for the third dose (booster vaccination) intramuscularly.